Life cycle of medical devices Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.

Slides:



Advertisements
Similar presentations
Elizabeth Mansfield, PhD OIVD Public meeting July 19, 2010
Advertisements

And the provisions of….. the Medical Devices Regulations Medical Devices Agency.
Overview of Device Regulations David Arvelo Small Business Representative.
Development of ISO standards for AD syringes SIGN Meeting Cambodia, October 2002 Injection technologies G Gerald Verollet.
Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.
Market surveillance under the General Product Safety Directive (GPSD)
Medical Devices Approval Process
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 1 Overview of Nursing Process, Clinical Reasoning, and Nursing Practice.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Chapter 17 Nursing Diagnosis
 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Careers, Roles, and Responsibilities. Duties and Responsibilities The role of CE started in early 1970s. The need for medical technology management arose.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
Staying healthy takes knowledge, a plan, and practicing healthful behaviors.
Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics.
Medical Devices IRB Determination IRB Member Continuing Education.
Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.
EHealth/mHealth Gisele Roesems Deputy Head of Unit Health and Well-Being DG CONNECT EUROPEAN COMMISSION 2 nd International Conference on Health Informatics.
Product Stewardship: Putting It into Practice GCWellon, Manager, Responsible Care Methanex Corporation June 2010.
Towards ISO Standards for AD syringes: Update from WHO Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.
Biomedical Engineering
ACCREDITED CONSULTANTS PVT LTD. (ACPL) WELCOMES YOU Your PHARMACOVIGILANCE PARTNER.
Promoting Health and Wellness
FEDERAL “RELATED SCIENCE ACTIVITIES” (RSA) AND MULTI-LEVEL REGULATION  INTRODUCTION AND CENTRAL PURPOSES  RSA AND LEVELS OF SCIENCE-BASED REGULATION.
Drug Safety and Risk Management Advisory Committee May 18-19, Overview of Drug Safety Challenges Gerald J. Dal Pan, MD, MHS Director Division of.
Integrating Compliance with Business: Developing and Implementing the Tysabri Risk Map Reintroduction of a Breakthrough Medical Product November 09, 2006.
1 CDRH: Minimizing Risk of TSE Agents in Medical Devices CDR Martha O’Lone, RN, BSN CDRH TSE Working Group Chair Infection Control Devices Branch DAGID.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
Responsible Care® Basic Awareness 1. DISCUSSION POINTS 2 WHAT IS RESPONSIBLE CARE®? HOW DOES RESPONSIBLE CARE® ADD VALUE? WHAT CAN YOU DO TO SUPPORT RESPONSIBLE.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
© Safeguarding public health Can Europe grow its Medtech industry and lead the world on medical device regulation? John Wilkinson 20 th September 2012.
July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
Learning Outcomes Discuss current trends and issues in health care and nursing. Describe the essential elements of quality and safety in nursing and their.
Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,
Show Chuan Memorial Hospital Phase I: Personnel movement & contact history (target high risk area – Emergency/fever segregation ward) SARS related medical.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Date: in 12 pts MARKET SURVEILLANCE IN THE EU ROLE IN THE NLF - EU ACTIONS and DEVELOPMENTS Rita L'Abbate European Commission DG ENTERPRISE AND INDUSTRY.
1 Chapter 9: Design for People; Ergonomics, Repairability, Safety, and Product Liability 9.1 Important Definitions Ergonomics (or Human engineering, or.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
Health and Consumers Health and Consumers Introduction to the new Medical Device Regulations and their impact on medical software DG for Internal Market,
FDA Perspective on Cardiovascular Device Development
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Adverse Event Reporting: Trials and Tribulations
Update on the National Postmarket Surveillance System
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
Device complications.
مقدمه في الرعايه الصحية HHSM301
جامعة الملك عبد العزيز كلية الاعمال رابغ
canada research chair in ethics, law & technology
Product Stewardship Policy
Medical Devices.
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Patient Involvement in the Development and Use of Safe Medicines Introductory Section – Concepts to Consider CIOMS XI WG Second Meeting October 23-24,
Er. Ajai Basil Consultant, Healthcare Technologies (Medical devices)
mHealth subject to European regulation Dutch Stefan Visscher, PhD
eHealth/mHealth Gisele Roesems
Use Antibiotics Responsibly
Presentation transcript:

Life cycle of medical devices Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi

The risk/benefit nature of medical devices The goal is to maximize benefit and to minimize risk

Definition of medical device Article, instrument, apparatus or machine for Diagnosis, treatment or prevention of disease or for detecting, measuring, restoring, correcting or modifying

Risk management in medical device Degree of risk Risk assessment of devices Risk management

Critical factors for medical device safety and effectiveness PRODUCT Pre-market review USE Post-market surveillance Presentation of product to user

The different phases of medical device From Conception to disposal

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal Pre-market On-market Post-market

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal Pre-Market

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal On-Market

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal Post-Market

The role of each participant/stakeholder Manufacturer Government User Importer/ Vendor Public

Life Cycle of a Medical Device Conception and Design ManufacturePackaging Labelling AdvertisingSaleUseDisposal MANUFACTURER VENDOR USER

The safety and effectiveness of medical devices demands co-operation among stakeholders The Manufacturer The vendor The users The Public The Governnent

The nature of medical device safety A risk management issue tied with device effectiveness/performance Throughout the life cycle of the device

Communication Between the Actors Manufacturer Government User Importer/ Vendor Public Shared Responsibility